Literature DB >> 9759635

Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.

Y Asada1, S Hara, A Tsuneyoshi, K Hatakeyama, A Kisanuki, K Marutsuka, Y Sato, Y Kamikubo, A Sumiyoshi.   

Abstract

Thrombus formation and neointimal growth are the critical events in restenosis after balloon angioplasty. However, the responses of diseased vessels to injuries caused by balloon angioplasty have not been well examined. We investigated the thrombus formation and neointimal development following the balloon injury to the previously induced neointima in the rabbit aorta and the effects of recombinant tissue factor pathway inhibitor (rTFPI) on these responses. Rabbit thoracic aortas were subjected to injury with a Fogarty 4F balloon catheter at 1.75 atm (first injury), and 4 weeks later the same vessels were subjected to the second injury with a Swan-Ganz 5F balloon catheter at 1.4 atm (mild-injury group) or 1.8 atm (severe-injury group), and immediately after that a retrograde bolus injection of rTFPI (100 microg/kg body weight) or saline was performed into the injured segments via the central tube of the Swan-Ganz catheter. Twenty minutes after the second injury, the injured surfaces were covered with platelet-rich thrombi in the mild-injury group and with fibrin-rich thrombi in the severe-injury group. Damaged intimal smooth muscle cells, which were immunohistochemically positive for tissue factor (TF), were observed beneath the fibrin-rich thrombi. The neointima 4 weeks after the second injury was significantly thicker in the severe-injury group than in the mild-injury group. The bolus infusion of rTFPI markedly inhibited fibrin formation on the injured surfaces, and significantly reduced the neointimal development in the severe-injury group at 4 weeks after the second injury. These results indicate that TF-dependent coagulation pathway is primarily responsible for fibrin-rich thrombus formation and may play an important role in neointimal development following the balloon injury to the rabbit aortic neointima. Additionally the bolus administration of rTFPI to the injured vessels could prevent mural thrombus formation and neointimal growth after balloon angioplasty.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759635

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

Review 1.  Tissue factor and thrombosis: The clot starts here.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Thromb Haemost       Date:  2010-06-10       Impact factor: 5.249

2.  Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.

Authors:  P Zoldhelyi; Z Q Chen; H S Shelat; J M McNatt; J T Willerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Inhibition of the tissue factor pathway of coagulation by recombinant nematode anticoagulant protein c2 during elective coronary stent implantation.

Authors:  A H M Moons; N R Bijsterveld; K T Koch; J C M Meijers; J G P Tijssen; T van der Poll; H R Büller; R J G Peters
Journal:  Neth Heart J       Date:  2004-02       Impact factor: 2.380

Review 4.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 5.  Inhibitors of the initiation of coagulation.

Authors:  Ilka Ott
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

6.  Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.

Authors:  Yung-Hsin Yeh; Shang-Hung Chang; Shin-Yu Chen; Chih-Jen Wen; Fu-Chan Wei; Rui Tang; Sam Achilefu; Tze-Chein Wun; Wei-Jan Chen
Journal:  Int J Cardiol       Date:  2017-04-06       Impact factor: 4.164

7.  Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.

Authors:  Li Wang; Christine Miller; Robert F Swarthout; Mohan Rao; Nigel Mackman; Mark B Taubman
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

8.  Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  C T Mitchell; A Kamineni; W Palmas; M Cushman
Journal:  Atherosclerosis       Date:  2009-04-24       Impact factor: 5.162

9.  Erythrocyte migration and gap formation in rabbit blood clots in vitro.

Authors:  T Ueki; F Yazama; T Horiuchi; M Yamada
Journal:  Vet Res Commun       Date:  2007-12-18       Impact factor: 2.459

10.  Association study to evaluate TFPI gene in CAD in Han Chinese.

Authors:  Ying Zhao; Yanbo Yu; Maowei Shi; Xi Yang; Xueqi Li; Feng Jiang; Yundai Chen; Xiaoli Tian
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.